drugset / Trial / NCT01810575

Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction

NCT01810575 ↗

Phase 2 Terminated 16 enrolled Warner Chilcott
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to assess the safety \& efficacy of a single dose of alprostadil cream with 2 concentrations of WC3036 compared to vehicle alone in men with erectile dysfunction.

Timeline

Start
2013-02
Primary completion
2013-04
Completion
2013-04

Outcome

Outcome not reported

Stopped: “Re-assessment of study”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alprostadil Unknown 330 ug —
Comparator WC3036 Unknown — —

Indications